As part of the Cancer Moonshot℠, the National Cancer Institute (NCI) intends to support the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network.
The overall purpose of the PE-CGS Network is twofold:
- To promote and support direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research; and
- To use such approaches for rigorous cancer genome sequencing programs addressing important knowledge gaps in the genomic characterizations of tumors.
Two new Funding Opportunity Announcements (FOAs) will support the Network's components:
- Several U2C Research Centers (RFA-CA-19-045) centered on addressing unique research knowledge gaps in the genomic characterizations of tumors.
- One U24 Coordinating Center (RFA-CA-19-046), which will facilitate trans-network collaborative activities.
Visit the FOA pages (linked above) for details on research interest areas, eligibility, budget, how to apply, and more. The application due date is October 30, 2019, by 5:00 p.m. local time of the submitting institution.
Learn more in two pre-application webinars presented by the NCI Division of Cancer Control and Population Sciences:
- August 7, 2019, 1-2 p.m. ET: Introduction Webinar and Q&A (Register)
- September 25, 2019, 1-2 p.m. ET: Frequently Asked Questions (Register)
Submit questions in advance to NCI_PE-CGS@mail.nih.gov. Note: While questions about the scope of the FOAs will be addressed during the webinar, questions about investigators' specific study aims will not.
For more information about these FOAs and webinars, email NCI_PE-CGS@mail.nih.gov.
Contacts
